Literature DB >> 11859949

Addition of pentoxifylline could reduce the side effects of fumaric acid esters in the treatment of psoriasis.

M Friedrich, W Sterry, A Klein, R Rückert, W D Döcke, K Asadullah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11859949     DOI： 10.1080/000155501317208390

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  10 in total

Review 1.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Giao Do; Camille Hua; Canelle Mazaud; Catherine Droitcourt; Carolyn Hughes; John R Ingram; Luigi Naldi; Olivier Chosidow; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2017-12-22

Review 2.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Liz Doney; Corinna Dressler; Camille Hua; Carolyn Hughes; Luigi Naldi; Sivem Afach; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2022-05-23

Review 3.  [Anti-inflammatory effects of pentoxifylline: importance in cardiac surgery].

Authors:  H V Groesdonk; M Heringlake; H Heinze
Journal:  Anaesthesist       Date:  2009-11       Impact factor: 1.041

4.  Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.

Authors:  Alessandra Lugaresi; Maria di Ioia; Daniela Travaglini; Erika Pietrolongo; Eugenio Pucci; Marco Onofrj
Journal:  Neuropsychiatr Dis Treat       Date:  2013-06-24       Impact factor: 2.570

5.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Liz Doney; Corinna Dressler; Camille Hua; Carolyn Hughes; Luigi Naldi; Sivem Afach; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2021-04-19

6.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Sivem Afach; Liz Doney; Corinna Dressler; Camille Hua; Canelle Mazaud; Céline Phan; Carolyn Hughes; Dru Riddle; Luigi Naldi; Ignacio Garcia-Doval; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2020-01-09

Review 7.  Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review including GRADE assessments.

Authors:  A Atwan; J R Ingram; R Abbott; M J Kelson; T Pickles; A Bauer; V Piguet
Journal:  Br J Dermatol       Date:  2016-08-29       Impact factor: 9.302

Review 8.  Oral fumaric acid esters for psoriasis.

Authors:  Ausama Atwan; John R Ingram; Rachel Abbott; Mark J Kelson; Timothy Pickles; Andrea Bauer; Vincent Piguet
Journal:  Cochrane Database Syst Rev       Date:  2015-08-10

Review 9.  Fumaric acid esters in the management of psoriasis.

Authors:  Deepak Mw Balak
Journal:  Psoriasis (Auckl)       Date:  2015-01-05

Review 10.  Current Landscape of NRF2 Biomarkers in Clinical Trials.

Authors:  Yoko Yagishita; Tonibelle N Gatbonton-Schwager; Melissa L McCallum; Thomas W Kensler
Journal:  Antioxidants (Basel)       Date:  2020-08-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.